Connection

Alicia Jenkins to Female

Back to Details
This is a "connection" page, showing publications Alicia Jenkins has written about Female.
Alicia Jenkins
Connection Strength
1.127
Female
  1. Relationship of low molecular weight fluorophore levels with clinical factors and fenofibrate effects in adults with type 2 diabetes. Sci Rep. 2021 09 21; 11(1):18708.
    View in: PubMed
    Score: 0.041
  2. Continuous subcutaneous insulin infusion alters microRNA expression and glycaemic variability in children with type 1 diabetes. Sci Rep. 2021 08 17; 11(1):16656.
    View in: PubMed
    Score: 0.041
  3. Serum urate and cardiovascular events in the DCCT/EDIC study. Sci Rep. 2021 07 09; 11(1):14182.
    View in: PubMed
    Score: 0.041
  4. Insulin micro-secretion in Type 1 diabetes and related microRNA profiles. Sci Rep. 2021 06 03; 11(1):11727.
    View in: PubMed
    Score: 0.040
  5. Long-Term Glycemic Variability and Vascular Complications in Type 2 Diabetes: Post Hoc Analysis of the FIELD Study. J Clin Endocrinol Metab. 2020 10 01; 105(10).
    View in: PubMed
    Score: 0.039
  6. Estimated insulin sensitivity in Type 1 diabetes adults using clinical and research biomarkers. Diabetes Res Clin Pract. 2020 Sep; 167:108359.
    View in: PubMed
    Score: 0.038
  7. HbA1c variability in adults with type 1 diabetes on continuous subcutaneous insulin infusion (CSII) therapy compared to multiple daily injection (MDI) treatment. BMJ Open. 2019 12 29; 9(12):e033059.
    View in: PubMed
    Score: 0.037
  8. Suboptimal behaviour and knowledge regarding overnight glycaemia in adults with type 1 diabetes is common. Intern Med J. 2018 09; 48(9):1080-1086.
    View in: PubMed
    Score: 0.033
  9. Shorter telomeres in adults with Type 1 diabetes correlate with diabetes duration, but only weakly with vascular function and risk factors. Diabetes Res Clin Pract. 2016 Jul; 117:4-11.
    View in: PubMed
    Score: 0.028
  10. Apolipoprotein-defined lipoproteins and apolipoproteins: associations with abnormal albuminuria in type 1 diabetes in the diabetes control and complications trial/epidemiology of diabetes interventions and complications cohort. J Diabetes Complications. 2013 Sep-Oct; 27(5):447-53.
    View in: PubMed
    Score: 0.023
  11. Plasma 1,5 anhydroglucitol levels, a measure of short-term glycaemia: assay assessment and lower levels in diabetic vs. non-diabetic subjects. Diabetes Res Clin Pract. 2012 Jan; 95(1):e17-9.
    View in: PubMed
    Score: 0.021
  12. An algorithm guiding patient responses to real-time-continuous glucose monitoring improves quality of life. Diabetes Technol Ther. 2011 Feb; 13(2):105-9.
    View in: PubMed
    Score: 0.020
  13. Associations among smoking status, lifestyle and lipoprotein subclasses. J Clin Lipidol. 2010 Nov-Dec; 4(6):522-30.
    View in: PubMed
    Score: 0.019
  14. Evaluation of an algorithm to guide patients with type 1 diabetes treated with continuous subcutaneous insulin infusion on how to respond to real-time continuous glucose levels: a randomized controlled trial. Diabetes Care. 2010 Jun; 33(6):1242-8.
    View in: PubMed
    Score: 0.019
  15. Increased coated-platelet levels in chronic haemodialysis patients. Nephrology (Carlton). 2009 Apr; 14(2):148-54.
    View in: PubMed
    Score: 0.017
  16. Cross-sectional associations of C-reactive protein with vascular risk factors and vascular complications in the DCCT/EDIC cohort. J Diabetes Complications. 2008 May-Jun; 22(3):153-63.
    View in: PubMed
    Score: 0.016
  17. Longitudinal analysis of low-molecular weight fluorophores in type 1 diabetes mellitus. J Med Invest. 2008 Feb; 55(1-2):29-36.
    View in: PubMed
    Score: 0.016
  18. Systemic and vascular inflammation is elevated in early IgA and type 1 diabetic nephropathies and relates to vascular disease risk factors and renal function. Nephrol Dial Transplant. 2005 Nov; 20(11):2420-6.
    View in: PubMed
    Score: 0.014
  19. Oxidative stress and high-density lipoprotein function in Type I diabetes and end-stage renal disease. Clin Sci (Lond). 2005 Jun; 108(6):497-506.
    View in: PubMed
    Score: 0.013
  20. In vivo glycated low-density lipoprotein is not more susceptible to oxidation than nonglycated low-density lipoprotein in type 1 diabetes. Metabolism. 2004 Aug; 53(8):969-76.
    View in: PubMed
    Score: 0.013
  21. Lipoproteins in the DCCT/EDIC cohort: associations with diabetic nephropathy. Kidney Int. 2003 Sep; 64(3):817-28.
    View in: PubMed
    Score: 0.012
  22. Serum lipoproteins in the diabetes control and complications trial/epidemiology of diabetes intervention and complications cohort: associations with gender and glycemia. Diabetes Care. 2003 Mar; 26(3):810-8.
    View in: PubMed
    Score: 0.011
  23. Optimal Frequency of Retinopathy Screening in Adolescents With Type 1 Diabetes: Markov Modeling Approach Based on 30 Years of Data. Diabetes Care. 2022 10 01; 45(10):2383-2390.
    View in: PubMed
    Score: 0.011
  24. Vitamin D Levels During Pregnancy Are Associated With Offspring Telomere Length: A Longitudinal Mother-Child Study. J Clin Endocrinol Metab. 2022 08 18; 107(9):e3901-e3909.
    View in: PubMed
    Score: 0.011
  25. Multifocal pupillographic objective perimetry for assessment of early diabetic retinopathy and generalised diabetes-related tissue injury in persons with type 1 diabetes. BMC Ophthalmol. 2022 Apr 13; 22(1):166.
    View in: PubMed
    Score: 0.011
  26. Relative leucocyte telomere length is associated with incident end-stage kidney disease and rapid decline of kidney function in type 2 diabetes: analysis from the Hong Kong Diabetes Register. Diabetologia. 2022 02; 65(2):375-386.
    View in: PubMed
    Score: 0.010
  27. Baseline extended zone retinal vascular calibres associate with sensory nerve abnormalities in adolescents with type 1 diabetes: A prospective longitudinal study. Diabet Med. 2021 11; 38(11):e14662.
    View in: PubMed
    Score: 0.010
  28. The relationship of neutrophil elastase and proteinase 3 with risk factors, and chronic complications in type 2 diabetes: A Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) sub-study. Diab Vasc Dis Res. 2021 Jul-Aug; 18(4):14791641211032547.
    View in: PubMed
    Score: 0.010
  29. FKBPL is associated with metabolic parameters and is a novel determinant of cardiovascular disease. Sci Rep. 2020 12 10; 10(1):21655.
    View in: PubMed
    Score: 0.010
  30. Six Months of Hybrid Closed-Loop Versus Manual Insulin Delivery With Fingerprick Blood Glucose Monitoring in Adults With Type 1 Diabetes: A Randomized, Controlled Trial. Diabetes Care. 2020 12; 43(12):3024-3033.
    View in: PubMed
    Score: 0.010
  31. Relationships of adipocyte-fatty acid binding protein and lipocalin 2 with risk factors and chronic complications in type 2 diabetes and effects of fenofibrate: A fenofibrate Intervention and event lowering in diabetes sub-study. Diabetes Res Clin Pract. 2020 Nov; 169:108450.
    View in: PubMed
    Score: 0.010
  32. Shortened Relative Leukocyte Telomere Length Is Associated With Prevalent and Incident Cardiovascular Complications in Type 2 Diabetes: Analysis From the Hong Kong Diabetes Register. Diabetes Care. 2020 09; 43(9):2257-2265.
    View in: PubMed
    Score: 0.009
  33. Vitamin D Metabolites and Binding Protein Predict Preeclampsia in Women with Type 1 Diabetes. Nutrients. 2020 Jul 10; 12(7).
    View in: PubMed
    Score: 0.009
  34. Extended-Zone Retinal Vascular Caliber and Risk of Diabetic Retinopathy in Adolescents with Type 1 Diabetes. Ophthalmol Retina. 2020 12; 4(12):1151-1157.
    View in: PubMed
    Score: 0.009
  35. Glucose and Counterregulatory Responses to Exercise in Adults With Type 1 Diabetes and Impaired Awareness of Hypoglycemia Using Closed-Loop Insulin Delivery: A Randomized Crossover Study. Diabetes Care. 2020 02; 43(2):480-483.
    View in: PubMed
    Score: 0.009
  36. Associations between circulating inflammatory markers, diabetes type and complications in youth. Pediatr Diabetes. 2019 12; 20(8):1118-1127.
    View in: PubMed
    Score: 0.009
  37. Haptoglobin Phenotype Modulates Lipoprotein-Associated Risk for Preeclampsia in Women With Type 1 Diabetes. J Clin Endocrinol Metab. 2019 10 01; 104(10):4743-4755.
    View in: PubMed
    Score: 0.009
  38. Serum pigment epithelium-derived factor: Relationships with cardiovascular events, renal dysfunction, and mortality in the Veterans Affairs Diabetes Trial (VADT) cohort. J Diabetes Complications. 2019 10; 33(10):107410.
    View in: PubMed
    Score: 0.009
  39. Glucose Control in Adults with Type 1 Diabetes Using a Medtronic Prototype Enhanced-Hybrid Closed-Loop System: A Feasibility Study. Diabetes Technol Ther. 2019 09; 21(9):499-506.
    View in: PubMed
    Score: 0.009
  40. Serum apolipoproteins and apolipoprotein-defined lipoprotein subclasses: a hypothesis-generating prospective study of cardiovascular events in T1D. J Lipid Res. 2019 08; 60(8):1432-1439.
    View in: PubMed
    Score: 0.009
  41. Attractions and barriers to Australian physician-researcher careers. Intern Med J. 2019 02; 49(2):171-181.
    View in: PubMed
    Score: 0.009
  42. Glucose Control Using a Standard Versus an Enhanced Hybrid Closed Loop System: A Randomized Crossover Study. Diabetes Technol Ther. 2019 01; 21(1):56-58.
    View in: PubMed
    Score: 0.009
  43. High plasma FGF21 levels predicts major cardiovascular events in patients treated with atorvastatin (from the Treating to New Targets [TNT] Study). Metabolism. 2019 04; 93:93-99.
    View in: PubMed
    Score: 0.008
  44. Effect of a high-egg diet on cardiometabolic risk factors in people with type 2 diabetes: the Diabetes and Egg (DIABEGG) Study-randomized weight-loss and follow-up phase. Am J Clin Nutr. 2018 06 01; 107(6):921-931.
    View in: PubMed
    Score: 0.008
  45. Response to Comment on Kelly et al. Subclinical First Trimester Renal Abnormalities Are Associated With Preeclampsia in Normoalbuminuric Women With Type 1 Diabetes. Diabetes Care 2018;41:120-127. Diabetes Care. 2018 06; 41(6):e102-e103.
    View in: PubMed
    Score: 0.008
  46. Apolipoprotein-defined lipoprotein subclasses, serum apolipoproteins, and carotid intima-media thickness in T1D. J Lipid Res. 2018 05; 59(5):872-883.
    View in: PubMed
    Score: 0.008
  47. Subclinical First Trimester Renal Abnormalities Are Associated With Preeclampsia in Normoalbuminuric Women With Type 1 Diabetes. Diabetes Care. 2018 01; 41(1):120-127.
    View in: PubMed
    Score: 0.008
  48. Circulating adipokines are associated with pre-eclampsia in women with type 1 diabetes. Diabetologia. 2017 12; 60(12):2514-2524.
    View in: PubMed
    Score: 0.008
  49. Incidence and Mortality Rates and Clinical Characteristics of Type 1 Diabetes among Children and Young Adults in Cochabamba, Bolivia. J Diabetes Res. 2017; 2017:8454757.
    View in: PubMed
    Score: 0.008
  50. Innovative technology shows impact of glycaemic control on peripheral retinal vessels in adolescents with type 1 diabetes. Diabetologia. 2017 10; 60(10):2103-2110.
    View in: PubMed
    Score: 0.008
  51. Baseline Circulating FGF21 Concentrations and Increase after Fenofibrate Treatment Predict More Rapid Glycemic Progression in Type 2 Diabetes: Results from the FIELD Study. Clin Chem. 2017 Jul; 63(7):1261-1270.
    View in: PubMed
    Score: 0.008
  52. Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial. Lancet Diabetes Endocrinol. 2017 08; 5(8):597-609.
    View in: PubMed
    Score: 0.008
  53. Closed-Loop Insulin Delivery for Adults with Type 1 Diabetes Undertaking High-Intensity Interval Exercise Versus Moderate-Intensity Exercise: A Randomized, Crossover Study. Diabetes Technol Ther. 2017 06; 19(6):340-348.
    View in: PubMed
    Score: 0.008
  54. "It Is Definitely a Game Changer": A Qualitative Study of Experiences with In-home Overnight Closed-Loop Technology Among Adults with Type 1 Diabetes. Diabetes Technol Ther. 2017 07; 19(7):410-416.
    View in: PubMed
    Score: 0.008
  55. Progressive Retinal Vasodilation in Patients With Type 1 Diabetes: A Longitudinal Study of Retinal Vascular Geometry. Invest Ophthalmol Vis Sci. 2017 05 01; 58(5):2503-2509.
    View in: PubMed
    Score: 0.008
  56. Metformin in adults with type 1 diabetes: Design and methods of REducing with MetfOrmin Vascular Adverse Lesions (REMOVAL): An international multicentre trial. Diabetes Obes Metab. 2017 04; 19(4):509-516.
    View in: PubMed
    Score: 0.008
  57. Glycemia, Treatment Satisfaction, Cognition, and Sleep Quality in Adults and Adolescents with Type 1 Diabetes When Using a Closed-Loop System Overnight Versus Sensor-Augmented Pump with Low-Glucose Suspend Function: A Randomized Crossover Study. Diabetes Technol Ther. 2016 12; 18(12):772-783.
    View in: PubMed
    Score: 0.007
  58. Liberal Glycemic Control in Critically Ill Patients With Type 2 Diabetes: An Exploratory Study. Crit Care Med. 2016 09; 44(9):1695-703.
    View in: PubMed
    Score: 0.007
  59. Retinal neuronal and vascular function in type 1 diabetes adults during glycaemic clamps. Clin Exp Pharmacol Physiol. 2016 Mar; 43(3):382-4.
    View in: PubMed
    Score: 0.007
  60. Circulating microRNA Biomarkers of Diabetic Retinopathy. Diabetes. 2016 Jan; 65(1):22-4.
    View in: PubMed
    Score: 0.007
  61. Opposite associations between alanine aminotransferase and ?-glutamyl transferase levels and all-cause mortality in type 2 diabetes: Analysis of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Metabolism. 2016 May; 65(5):783-793.
    View in: PubMed
    Score: 0.007
  62. Associations between intensive diabetes therapy and NMR-determined lipoprotein subclass profiles in type 1 diabetes. J Lipid Res. 2016 Feb; 57(2):310-7.
    View in: PubMed
    Score: 0.007
  63. Nuclear magnetic resonance-determined lipoprotein subclasses and carotid intima-media thickness in type 1 diabetes. Atherosclerosis. 2016 Jan; 244:93-100.
    View in: PubMed
    Score: 0.007
  64. Relationship of fibroblast growth factor 21 with baseline and new on-study microvascular disease in the Fenofibrate Intervention and Event Lowering in Diabetes study. Diabetologia. 2015 Sep; 58(9):2035-44.
    View in: PubMed
    Score: 0.007
  65. Trace elements as predictors of preeclampsia in type 1 diabetic pregnancy. Nutr Res. 2015 May; 35(5):421-30.
    View in: PubMed
    Score: 0.007
  66. Serum 25-hydroxyvitamin D: a predictor of macrovascular and microvascular complications in patients with type 2 diabetes. Diabetes Care. 2015 Mar; 38(3):521-8.
    View in: PubMed
    Score: 0.006
  67. Sex differences in retinal microvasculature through puberty in type 1 diabetes: are girls at greater risk of diabetic microvascular complications? Invest Ophthalmol Vis Sci. 2014 Dec 04; 56(1):571-7.
    View in: PubMed
    Score: 0.006
  68. The relationship of fibroblast growth factor 21 with cardiovascular outcome events in the Fenofibrate Intervention and Event Lowering in Diabetes study. Diabetologia. 2015 Mar; 58(3):464-73.
    View in: PubMed
    Score: 0.006
  69. Favourable effects of fenofibrate on lipids and cardiovascular disease in women with type 2 diabetes: results from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Diabetologia. 2014 Nov; 57(11):2296-303.
    View in: PubMed
    Score: 0.006
  70. Plasma total homocysteine and carotid intima-media thickness in type 1 diabetes: a prospective study. Atherosclerosis. 2014 Sep; 236(1):188-195.
    View in: PubMed
    Score: 0.006
  71. HDL-C and HDL-C/ApoA-I predict long-term progression of glycemia in established type 2 diabetes. Diabetes Care. 2014 Aug; 37(8):2351-8.
    View in: PubMed
    Score: 0.006
  72. Elevated circulation levels of an antiangiogenic SERPIN in patients with diabetic microvascular complications impair wound healing through suppression of Wnt signaling. J Invest Dermatol. 2014 Jun; 134(6):1725-1734.
    View in: PubMed
    Score: 0.006
  73. Apolipoprotein-defined and NMR lipoprotein subclasses in the veterans affairs diabetes trial. J Diabetes Complications. 2013 Nov-Dec; 27(6):627-32.
    View in: PubMed
    Score: 0.006
  74. The metabolic syndrome and CVD outcomes for a central Australian cohort. Diabetes Res Clin Pract. 2013 Jun; 100(3):e70-3.
    View in: PubMed
    Score: 0.006
  75. Serum inflammatory markers and preeclampsia in type 1 diabetes: a prospective study. Diabetes Care. 2013 Jul; 36(7):2054-61.
    View in: PubMed
    Score: 0.006
  76. Long-term fenofibrate therapy increases fibroblast growth factor 21 and retinol-binding protein 4 in subjects with type 2 diabetes. J Clin Endocrinol Metab. 2012 Dec; 97(12):4701-8.
    View in: PubMed
    Score: 0.006
  77. Normalized NEFA dynamics during an OGTT after islet transplantation. Transplantation. 2012 Oct 15; 94(7):e49-51.
    View in: PubMed
    Score: 0.006
  78. Serum apolipoproteins are associated with systemic and retinal microvascular function in people with diabetes. Diabetes. 2012 Jul; 61(7):1785-92.
    View in: PubMed
    Score: 0.005
  79. High concentrations of AGE-LDL and oxidized LDL in circulating immune complexes are associated with progression of retinopathy in type 1 diabetes. Diabetes Care. 2012 Jun; 35(6):1333-40.
    View in: PubMed
    Score: 0.005
  80. Plasma lipoproteins and preeclampsia in women with type 1 diabetes: a prospective study. J Clin Endocrinol Metab. 2012 May; 97(5):1752-62.
    View in: PubMed
    Score: 0.005
  81. Plantar fascia thickness is longitudinally associated with retinopathy and renal dysfunction: a prospective study from adolescence to adulthood. J Diabetes Sci Technol. 2012 Mar 01; 6(2):348-55.
    View in: PubMed
    Score: 0.005
  82. Retinal vascular geometry predicts incident renal dysfunction in young people with type 1 diabetes. Diabetes Care. 2012 Mar; 35(3):599-604.
    View in: PubMed
    Score: 0.005
  83. Benefits and safety of long-term fenofibrate therapy in people with type 2 diabetes and renal impairment: the FIELD Study. Diabetes Care. 2012 Feb; 35(2):218-25.
    View in: PubMed
    Score: 0.005
  84. Retinal arteriolar tortuosity is associated with retinopathy and early kidney dysfunction in type 1 diabetes. Am J Ophthalmol. 2012 Jan; 153(1):176-83.e1.
    View in: PubMed
    Score: 0.005
  85. Retinal vascular geometry predicts incident retinopathy in young people with type 1 diabetes: a prospective cohort study from adolescence. Diabetes Care. 2011 Jul; 34(7):1622-7.
    View in: PubMed
    Score: 0.005
  86. Serum carotenoids and fat-soluble vitamins in women with type 1 diabetes and preeclampsia: a longitudinal study. Diabetes Care. 2011 Jun; 34(6):1258-64.
    View in: PubMed
    Score: 0.005
  87. LDL-containing immune complexes in the DCCT/EDIC cohort: associations with lipoprotein subclasses. J Diabetes Complications. 2011 Mar-Apr; 25(2):73-82.
    View in: PubMed
    Score: 0.005
  88. Lipid treatment guidelines and cardiovascular risk for Aboriginal people in Central Australia. Med J Aust. 2009 May 18; 190(10):552-6.
    View in: PubMed
    Score: 0.004
  89. NMR-determined lipoprotein subclass profile predicts type 2 diabetes. Diabetes Res Clin Pract. 2009 Jan; 83(1):132-9.
    View in: PubMed
    Score: 0.004
  90. Quantitative assessment of early diabetic retinopathy using fractal analysis. Diabetes Care. 2009 Jan; 32(1):106-10.
    View in: PubMed
    Score: 0.004
  91. Risk factors related to inflammation and endothelial dysfunction in the DCCT/EDIC cohort and their relationship with nephropathy and macrovascular complications. Diabetes Care. 2008 Oct; 31(10):2006-12.
    View in: PubMed
    Score: 0.004
  92. Retinal arteriolar dilation predicts retinopathy in adolescents with type 1 diabetes. Diabetes Care. 2008 Sep; 31(9):1842-6.
    View in: PubMed
    Score: 0.004
  93. Association between p.Leu54Met polymorphism at the paraoxonase-1 gene and plantar fascia thickness in young subjects with type 1 diabetes. Diabetes Care. 2008 Aug; 31(8):1585-9.
    View in: PubMed
    Score: 0.004
  94. Low-density lipoprotein particles and risk of intracerebral haemorrhage in subjects with cerebrovascular disease. Eur J Cardiovasc Prev Rehabil. 2007 Jun; 14(3):413-8.
    View in: PubMed
    Score: 0.004
  95. Association between PON 1 polymorphisms, PON activity and diabetes complications. J Diabetes Complications. 2006 Sep-Oct; 20(5):322-8.
    View in: PubMed
    Score: 0.004
  96. Retinal vascular caliber and risk of retinopathy in young patients with type 1 diabetes. Ophthalmology. 2006 Sep; 113(9):1499-503.
    View in: PubMed
    Score: 0.004
  97. Associations of inflammatory and hemostatic variables with the risk of recurrent stroke. Stroke. 2005 Oct; 36(10):2143-7.
    View in: PubMed
    Score: 0.003
  98. Prediction of myocardial infarction by N-terminal-pro-B-type natriuretic peptide, C-reactive protein, and renin in subjects with cerebrovascular disease. Circulation. 2005 Jul 05; 112(1):110-6.
    View in: PubMed
    Score: 0.003
  99. Lipid-derived modifications of plasma proteins in experimental and human diabetes. Ann N Y Acad Sci. 2005 Jun; 1043:404-12.
    View in: PubMed
    Score: 0.003
  100. Effect of intensive glycemic control on levels of markers of inflammation in type 1 diabetes mellitus in the diabetes control and complications trial. Circulation. 2005 May 17; 111(19):2446-53.
    View in: PubMed
    Score: 0.003
  101. Chemical modification of proteins during peroxidation of phospholipids. J Lipid Res. 2005 Jul; 46(7):1440-9.
    View in: PubMed
    Score: 0.003
  102. Apolipoprotein C-III protein concentrations and gene polymorphisms in Type 1 diabetes: associations with microvascular disease complications in the DCCT/EDIC cohort. J Diabetes Complications. 2005 Jan-Feb; 19(1):18-25.
    View in: PubMed
    Score: 0.003
  103. Prediction of heart failure by amino terminal-pro-B-type natriuretic peptide and C-reactive protein in subjects with cerebrovascular disease. Hypertension. 2005 Jan; 45(1):69-74.
    View in: PubMed
    Score: 0.003
  104. Apolipoprotein C-III protein concentrations and gene polymorphisms in type 1 diabetes: associations with lipoprotein subclasses. Metabolism. 2004 Oct; 53(10):1296-304.
    View in: PubMed
    Score: 0.003
  105. Critical evaluation of adult treatment panel III criteria in identifying insulin resistance with dyslipidemia. Diabetes Care. 2004 Apr; 27(4):978-83.
    View in: PubMed
    Score: 0.003
  106. Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort. Invest Ophthalmol Vis Sci. 2004 Mar; 45(3):910-8.
    View in: PubMed
    Score: 0.003
  107. Low plasma concentrations of diet-derived antioxidants in association with microalbuminuria in Indigenous Australian populations. Clin Sci (Lond). 2003 Nov; 105(5):569-75.
    View in: PubMed
    Score: 0.003
  108. Inflammation and vascular endothelial activation in an Aboriginal population: relationships to coronary disease risk factors and nutritional markers. Med J Aust. 2003 May 19; 178(10):495-500.
    View in: PubMed
    Score: 0.003
  109. Fibrinogen is a marker for nephropathy and peripheral vascular disease in type 1 diabetes: studies of plasma fibrinogen and fibrinogen gene polymorphism in the DCCT/EDIC cohort. Diabetes Care. 2003 May; 26(5):1439-48.
    View in: PubMed
    Score: 0.003
  110. Value of the micropig model of menopause in the assessment of benefits and risks of postmenopausal therapies for cardiovascular and reproductive tissues. Fertil Steril. 2003 Mar; 79 Suppl 1:779-88.
    View in: PubMed
    Score: 0.003
  111. Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance. Diabetes. 2003 Feb; 52(2):453-62.
    View in: PubMed
    Score: 0.003
  112. Foot problems and foot care practices in diabetes. A survey of public and private diabetes clinics affiliated with a university hospital. J S C Med Assoc. 2002 Dec; 98(8):305-10.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.